The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis

Medical Hypotheses

Volumn 72, Issue 3, 2009, Pages 291-293

  Thachil, Jecko ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; DISEASE COURSE; DISEASE MODEL; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; IMMUNOPATHOLOGY; LUNG; LUNG FIBROSIS; MEGAKARYOCYTE; MYELOFIBROSIS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

HUMANS; LUNG; MEGAKARYOCYTES; MODELS, IMMUNOLOGICAL; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 59249089573     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.09.045     Document Type: Article

References (33)

1. Denton C.P., Black C.M., and Abraham D.J. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2 (2006) 134-144
2. Postlethwaite A.E., and Chiang T.M. Platelet contributions to the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 19 (2007) 574-579
3. Reilly J.T. Pathogenesis of idiopathic myelofibrosis: present status and future directions. Br J Haematol 88 (1994) 1
4. Terui T., Niitsu Y., Mahara K., Fujisaki Y., Urushizaki Y., Mogi Y., et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 75 (1990) 1540-1548
5. Breton-Gorius J. On the alleged phagocytosis by megakaryocytes. Br J Haematol 47 (1981) 635-636
6. Cashell A.W., and Buss D.H. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. Ann Hematol 64 (1992) 273-276
7. Centurione L., Di Baldassarre A., Zingariello M., Bosco D., Gatta V., Rana R.A., et al. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood 104 (2004) 3573-3580
8. Schmitt A., Jouault H., Guichard J., Wendling F., Drouin A., and Cramer E.M. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 96 (2000) 1342-1347
9. Evangelista V., Manarini S., Sideri R., Rotondo S., Martelli N., Piccoli A., et al. Platelet/ polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93 (1999) 876
10. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 23 (2005) 8520-8530
11. Zucker-Franklin D., and Philipp C.S. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol 157 (2000) 69-74
12. Trowbridge E.A., Martin J.F., and Slater D.N. Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation. Thromb Res 28 (1982) 461-475
13. Kallinikos-Maniatis A. Megakaryocytes and platelets in central venous and arterial blood. Acta Haematol 42 (1969) 330-335
14. Martin J.F., Slater D.N., and Trowbridge E.A. Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease. Lancet 1 (1983) 793-796
15. Mandal R.V., Mark E.J., and Kradin R.L. Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol 83 (2007) 327-331
16. Wells S., Sissons M., and Hasleton P.S. Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns. Histopathology 8 (1984) 517-527
17. Kowal-Bielecka O., Kowal K., Lewszuk A., Bodzenta-Lukaszyk A., Walecki J., and Sierakowski S. Links Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Ann Rheum Dis 64 (2005) 484-486
18. McLaren K.M., and Pepper D.S. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets. J Clin Pathol 35 (1982) 1227-1231
19. Crestani B., Seta N., Palazzo E., Rolland C., Venembre P., Dehoux M., et al. Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 150 (1994) 1363-1367
20. Obayashi Y., Yamadori I., Fujita J., Yoshinouchi T., Ueda N., and Takahara J. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 112 (1997) 1338-1343
21. Popat U., Frost A., Liu E., May R., and Bag R. New onset of myelofibrosis in association with pulmonary arterial hypertension. Ann Intern Med 143 (2005) 466-467
22. Cortelezzi A., Gritti G., Del Papa N., Pasquini M.C., Calori R., Gianelli U., et al. Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status. Leukemia 22 (2008) 646-649
23. Zetterberg E., Popat U., Hasselbalch H., Prchal J., and Palmblad J. Angiogenesis in pulmonary hypertension with myelofibrosis. Haematologica 93 (2008) 945-946
24. Dickinson C.J., and Martin J.F. MK and platelet clumps as the cause of finger clubbing. Lancet 2 (1987) 1434-1435
25. Atkinson S., and Fox S.B. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 203 (2004) 721-728
26. Brough A.J., Jones D., Page R.H., and Mizukami I. Dermal erythropoiesis in neonatal infants. A manifestation of intra-uterine viral disease. Pediatrics 40 (1967) 627-635
27. Pagerols X., Curc N., Martí J.M., and Vives P. Cutaneous extramedullary haematopoiesis associated with blast crisis in myelofibrosis. Clin Exp Dermatol 23 (1998) 296-297
28. Kawakami T., Kimura S., Kato M., Mizoguchi M., and Soma Y. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis. J Am Acad Dermatol 58 (2008) 703-706
29. Postlethwaite A.E., Shigemitsu H., and Kanangat S. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 16 (2004) 733-738
30. Tabata C., Tabata R., Kadokawa Y., Hisamori S., Takahashi M., Mishima M., et al. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J Immunol 179 (2007) 708-714
31. National Pulmonary Hypertension Centres of the UK and Ireland. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Thorax 2008;63(Suppl. 2):ii1-ii41.
32. Battinelli E., and Loscalzo J. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood 95 (2000) 3451-3459
33. Sulkowski S., Sulkowska M., and Musiatowicz B. The effects of cyclophosphamide on pulmonary thrombopoiesis in rats. Histol Histopathol 13 (1998) 1027-1036